larazotide (AT1001) - 9 Meters Biopharma
cendakimab (CC-93538) - AbbVie, BMS
latiglutenase (IMGX003) - Entero Therap
Cinqair (reslizumab) - Merck (MSD), UCB, Teva
tofacitinib - Generic mfg.
Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
Nucala (mepolizumab) - GSK
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
TAK-227 - Takeda
Rinvoq (upadacitinib) - AbbVie
Entyvio (vedolizumab) - Takeda
Fasenra (benralizumab) - AstraZeneca
Velsipity (etrasimod) - Pfizer
Dupixent (dupilumab) - Sanofi, Regeneron
dectrekumab (QAX576) - Novartis
ordesekimab (AMG 714) - Amgen, Sanofi
http://www.ncbi.nlm.nih.gov/pubmed/40281872
 
Claudio Romano; Valeria Dipasquale
 
Apr 27, 2025
 
Next